top of page
Search
  • Alfred Lagaya

GENEWIZ presents: Novel Sequencing & Synthetic Solutions for AAV-based Gene Therapy Research

Updated: Apr 12, 2021




Inverted terminal repeats (ITRs) of Adeno-associated virus (AAV) play a key role in virus replication and encapsidation, and are also important in viral genome integration and excision from the host genome. However, due to their high GC content and secondary structures, AAV plasmid ITRs are frequently mutated during plasmid production in E. coli., reducing experiment reproducibility and causing delays if ITR mutations are left undetected.


In this presentation, Dr. Elizabeth Louie from GENEWIZ will discuss our novel Adeno-Associated virus (AAV) plasmid DNA sequencing (RUO/GLP), preparation and synthesis solutions for rAAV production while confirming, maintaining and correcting inverted terminal repeat (ITR) regions. In addition, she will also talk about GENEWIZ’s proprietary Sanger & NGS viral genome sequencing confirmation solutions post AAV virus packaging including at the regulatory level to optimize AAV production for gene therapy development.

103 views1 comment

1件のコメント


julie
2020年11月13日

We really enjoyed working with the Genewiz team on their virtual webinar covering their novel Adeno-Associated virus (AAV) plasmid DNA sequencing (RUO/GLP), preparation and synthesis solutions for rAAV production and their Sanger & NGS viral genome sequencing confirmation solutions post AAV virus packaging. Dr. Elizabeth Louie proves she is a seasoned presenter with extensive scientific knowledge. The webinar content brought a great audience together specializing in cell and gene therapy. We wish the Genewiz team the best on their efforts to help scientists in in vivo gene therapy clinical trials and beyond!

いいね!
bottom of page